People experience harm in different, complex ways at both the structural and interpersonal levels. When people are criminalized because of illicit drug use, criminalized labor (like drug selling or sex work), or other stigmatized actions that are often survival behaviors, they are also more vulnerable to experiencing interpersonal violence.
As the United States heads into its third year in the fight against COVID-19, Americans have seen firsthand the importance of a robust and comprehensive response to public health emergencies and epidemics. The same is true for chronic viral hepatitis, a condition that impacts an estimated 3.3 million Americans. Without comprehensive plans to eliminate viral hepatitis, the US will fall short of reaching the World Health Organization’s (WHO’s) goal of fully eliminating the virus by 2030.
Hear from pharmacists across the country who are providing viral hepatitis care in unique settings. The webinar discusses opportunities and barriers to increasing pharmacist involvement in viral hepatitis care.
The National Harm Reduction Technical Assistance Center (NHRTAC) Training Deck on Harm Reduction and Syringe Access is a customizable PowerPoint slide deck training designed to provide an overview on the foundations of harm reduction philosophy and practice, drug user health issues and trends, and increase cultural competence and humility when working with people who use drugs.
On Thursday, June 11, HepVu convened a webinar to discuss the impact of COVID-19 on harm reduction services, issues encountered on the ground, and potential solutions.
In collaboration with the National Viral Hepatitis Roundtable (NVHR), the Hepatitis Education Project (HEP), NASTAD, Hep B United, Hepatitis B Foundation, and National Association of County Health Officials (NACCHO), HepVu created a factsheet outlining the impact of the COVID-19 pandemic on viral hepatitis and the experiences of clinical providers, community-based organizations, and health departments during COVID-19.
The plan highlights goal-oriented objectives and strategies aimed at ultimately eliminating viral hepatitis as a public health threat in the U.S.
This technical package provides a broad framework for new and existing SSPs to ensure needs-based service delivery, reduce harms related to injection drug use, and link participants to services that support their health and wellness.
This fact sheet can help you understand and answer questions about what your blood tests mean and if you are infected, protected or at risk for hepatitis B.
